FPR2 participates in epithelial ovarian cancer (EOC) progression through RhoA-mediated M2 macrophage polarization

BACKGROUND: In our previous study, we found that formyl peptide receptor 2 (FPR2) promoted the invasion and metastasis of epithelial ovarian cancer (EOC) and could be a prognostic marker for EOC. In this study, we aimed to study the possible mechanism of FPR2 in promoting EOC progression. METHODS: E...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xiaohui, He, Juan, Wang, Qiong, Liu, Yaqiong, Chen, Weiwei, Shi, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686243/
https://www.ncbi.nlm.nih.gov/pubmed/34930387
http://dx.doi.org/10.1186/s13048-021-00932-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686243/
https://www.ncbi.nlm.nih.gov/pubmed/34930387
http://dx.doi.org/10.1186/s13048-021-00932-8

Ejemplares similares